Cardiovascular Diseases Clinical Trial
To examine some of the psychosocial predictors of poor outcome among revascularized coronary artery disease patients.
BACKGROUND:
Percutaneous coronary revascularization procedures are increasingly used in the treatment of
coronary artery disease, with approximately 300,000 interventions performed each year.
Despite new developments in cardiology such as intra-coronary stents and anticoagulant
pharmacological treatments, a major problem remains the frequent occurrence of coronary
restenosis and new cardiac events within six months after the intervention. These adverse
outcomes occur in one out of four patients and have substantial impact on the costs of
medical care and patients' quality of life. Research indicated that hemostatic factors
(e.g., fibrinogen, von Willebrand factor, and plasminogen activator inhibitor) promote the
formation of blood clots and that these factors predict coronary restenosis. Moreover, prior
longitudinal studies have also demonstrated that the psychosocial traits of hostility and
depression affect clinical progression of coronary disease. These psychosocial factors
significantly predict adverse long-term outcome after revascularization and both hostility
and depression are known to affect blood clotting factors. In addition, acute mental and
physical stress are reported to affect blood clotting factors (coagulation and fibrinolysis)
and responses to stress are reported to be more pronounced in hostile individuals. However,
previous research on predictors of adverse clinical outcome after percutaneous coronary
revascularization has not examined stress-induced changes in hemostatic factors and the
consequences of these responses for progression of coronary artery disease. Therefore, the
study investigates whether psychosocial factors and responses to acute mental stress affect
measures of the blood clotting process that are involved in progression of coronary disease,
thereby increasing the risk of an adverse prognosis following percutaneous coronary
revascularization. This study may improve the identification of patients at risk for
recurrent cardiac events and provide further understanding of the pathophysiological
mechanisms involved in the progression of coronary artery disease.
DESIGN NARRATIVE:
The study investigated whether psychosocial factors and responses to acute mental stress
affected measures of the blood clotting process that are involved in progression of coronary
disease, thereby increasing the risk of an adverse prognosis following percutaneous coronary
revascularization. This study helped to improve the identification of patients at risk for
recurrent cardiac events and provided further understanding of the pathophysiological
mechanisms involved in the progression of coronary artery disease.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|